Seeking Alpha

Seeking Alpha Portfolio App for iPad

22 people get CYPB articles and Market Currents by email alert.

Get email alerts on CYPB »

CYPB

Cypress Bioscience Inc.

5/23/2013, 2:07 AM ET

Quote & Headlines StockTalk

CYPB is defunct.

HEADLINES:

ALL | PRO | FOCUS | RELATED | TRANSCRIPTS | NEWS & PR

CYPB

Merger Arbitrage Mondays: December 20, 2010
Asif Suria • Mon, Dec 20, 2010
CYPB

Ramius’ Persistence Pays Off: Cypress Biosciences Finally Says Yes - Biotech's Latest M&A Action
The Burrill Report • Sun, Dec 19, 2010
CYPB

Cypress Rises 20 Percent on the Possibility of a Sale to Ramius: Biotech's Latest M&A Action
The Burrill Report • Sun, Dec 12, 2010
CYPB

The 20 Most Undervalued Biotech Stocks
Kapitall • Tue, Nov 9, 2010 • 1 Comment
CYPB

Cypress and Hedge Fund Ramius Renew Battle Over Control
The Burrill Report • Sun, Oct 3, 2010
CYPB

Crucell Deal Will Expand J&J’s Position in Growing Vaccine Market: Biotech's Latest M&A Activity
The Burrill Report • Sun, Sep 19, 2010 • 5 Comments
CYPB

Hedge Fund Manager Takes Bid Directly to Cypress Shareholders
The Burrill Report • Sun, Sep 19, 2010
CYPB

Narrow Stock Gains Enough to Hand Nasdaq Its Sixth Straight Gain
Midnight Trader • Wed, Sep 15, 2010
CYPB

Roche Dominates the Biotech Deal Flow
The Burrill Report • Mon, Aug 30, 2010
CYPB

Cypress Risks Deepening Disquiet With Another Spending Spree
EP Vantage • Mon, Aug 30, 2010 • 2 Comments
CYPB

Can Corporate Cash Save U.S. Stock Market?
Investment U • Wed, Aug 25, 2010
CYPB

Jazz FDA Panel Meeting: Leaning on the Positive Outcome Side
Kaushik Paul • Fri, Aug 20, 2010 • 6 Comments
CYPB

FDA Dislikes Novartis on Facebook: Biotech's Latest Mishaps
The Burrill Report • Sun, Aug 8, 2010
CYPB

Merger Arbitrage Mondays: July 26, 2010
Asif Suria • Mon, Jul 26, 2010
CYPB

Weekly Street Sentiment: Good Earnings Make Good Markets
First Coverage • Mon, Jul 26, 2010 • 3 Comments
CYPB

Life Sciences Deals Go on Summer Break
The Burrill Report • Sun, Jul 25, 2010 • 2 Comments
CYPB

Maverick Capital Focuses on Tech and Health Stocks
Market Folly • Mon, Feb 22, 2010
CYPB

Cypress Bioscience: Investing in Pain
Richard Sater • Tue, May 12, 2009 • 1 Comment
CYPB

FDA, Clinical Trial Calendar Updates: Actelion, Merck Discontinue Partnership
Mike Havrilla • Tue, Apr 21, 2009 • 10 Comments
CYPB

Bullish Thesis for Biotech Remains Intact
Michael Becker • Thu, Feb 5, 2009 • 1 Comment

To learn more about Seeking Alpha Pro, click here.

CYPB

Cypress and Hedge Fund Ramius Renew Battle Over Control
The Burrill Report • Sun, Oct 3, 2010
CYPB

Hedge Fund Manager Takes Bid Directly to Cypress Shareholders
The Burrill Report • Sun, Sep 19, 2010
CYPB

Cypress Risks Deepening Disquiet With Another Spending Spree
EP Vantage • Mon, Aug 30, 2010 • 2 Comments
CYPB

Cypress Bioscience: About To Reverse Course?
Badger The Lion • Thu, Aug 21, 2008 • 2 Comments

CYPB

Merger Arbitrage Mondays: December 20, 2010
Asif Suria • Mon, Dec 20, 2010
CYPB

Ramius’ Persistence Pays Off: Cypress Biosciences Finally Says Yes - Biotech's Latest M&A Action
The Burrill Report • Sun, Dec 19, 2010
CYPB

Cypress Rises 20 Percent on the Possibility of a Sale to Ramius: Biotech's Latest M&A Action
The Burrill Report • Sun, Dec 12, 2010
CYPB

The 20 Most Undervalued Biotech Stocks
Kapitall • Tue, Nov 9, 2010 • 1 Comment
CYPB

Crucell Deal Will Expand J&J’s Position in Growing Vaccine Market: Biotech's Latest M&A Activity
The Burrill Report • Sun, Sep 19, 2010 • 5 Comments
CYPB

Narrow Stock Gains Enough to Hand Nasdaq Its Sixth Straight Gain
Midnight Trader • Wed, Sep 15, 2010
CYPB

Roche Dominates the Biotech Deal Flow
The Burrill Report • Mon, Aug 30, 2010
CYPB

Can Corporate Cash Save U.S. Stock Market?
Investment U • Wed, Aug 25, 2010
CYPB

Jazz FDA Panel Meeting: Leaning on the Positive Outcome Side
Kaushik Paul • Fri, Aug 20, 2010 • 6 Comments
CYPB

FDA Dislikes Novartis on Facebook: Biotech's Latest Mishaps
The Burrill Report • Sun, Aug 8, 2010
CYPB

Merger Arbitrage Mondays: July 26, 2010
Asif Suria • Mon, Jul 26, 2010
CYPB

Weekly Street Sentiment: Good Earnings Make Good Markets
First Coverage • Mon, Jul 26, 2010 • 3 Comments
CYPB

Life Sciences Deals Go on Summer Break
The Burrill Report • Sun, Jul 25, 2010 • 2 Comments
CYPB

Maverick Capital Focuses on Tech and Health Stocks
Market Folly • Mon, Feb 22, 2010
CYPB

Cypress Bioscience: Investing in Pain
Richard Sater • Tue, May 12, 2009 • 1 Comment
CYPB

FDA, Clinical Trial Calendar Updates: Actelion, Merck Discontinue Partnership
Mike Havrilla • Tue, Apr 21, 2009 • 10 Comments
CYPB

Bullish Thesis for Biotech Remains Intact
Michael Becker • Thu, Feb 5, 2009 • 1 Comment
CYPB

Looking for the Biotech Breakout
Jeff Pierce • Mon, Jan 19, 2009 • 5 Comments
CYPB

Thursday Options Update: BAC, C, AAPL, CYPB & SQNM
Interactive Brokers • Thu, Jan 15, 2009 • 3 Comments
CYPB

Trading FDA Decisions: Cypress Bioscience Soars, A Trio of Buys
Mike Havrilla • Thu, Jan 15, 2009 • 4 Comments

There are no Transcripts on CYPB.

CYPB

Time to Buy Cypress Semiconductor?

at CNBC.com (Dec 5, 2011)
CYPB

Movers & Shakers: Wednesday’s biggest gaining and declining stocks

at MarketWatch.com (Dec 15, 2010)
CYPB

Biotech Stocks: Maxygen plunges; drug indexes gain

at MarketWatch.com (Dec 15, 2010)
CYPB

Movers & Shakers: Friday’s biggest gaining and declining stocks

at MarketWatch.com (Dec 10, 2010)
CYPB

Movers & Shakers: Wednesday’s biggest gaining and declining stocks

at MarketWatch.com (Sep 15, 2010)
CYPB

Movers & Shakers: Monday's biggest gaining and declining stocks

at MarketWatch.com (Jul 19, 2010)
CYPB

Corrections: Cypress rallies on buyout bid

at MarketWatch.com (Jul 19, 2010)
CYPB

Biotech Stocks: Cypress rallies on takeover bid

at MarketWatch.com (Jul 19, 2010)
CYPB

Israel Stocks: Israel stocks up; FDA moves on 2 medical firms

at MarketWatch.com (Jun 21, 2010)
CYPB

Israel Stocks: Israel stocks up; ICL and BiolineRx in focus

at MarketWatch.com (Jun 20, 2010)

Company Description

Currently, there's no company description for CYPB.

Country: United States

candlestickpicks
CYPB completed a White Hammer candlestick pattern on 12/21/2010. Look for an upward price movement on 12/22/2010
12/21/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Asif Suria
Cypress Bioscience $CYPB received an offer from Ramiusto acquire all of the outstanding common shares of Cypress
12/15/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Asif Suria
Cypress Board Rejects Ramius' $6.00 All-Cash Offer $CYPB
12/14/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Asif Suria
Ramius sweetens bid for Cypress Bioscience for 2nd time $CYPB
12/10/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Alex B. Gray
Cypress Bioscience $CYPB to sell its diagnostic business to Exagen Diagnostics for up to $8 million with upfront and milestone payments.
10/9/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Asif Suria
Cypress Bioscience Board of Directors to Review Unsolicited Tender Offer from Ramius LLC $CYPB
9/15/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

dukeduke
just sold my CYPB. Shortterm it will be down on rejection of offer, but Ramius will come back with a higher offer as they see $$$.
8/6/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

dukeduke
CYPB rejected Ramius offer as "grossly undervalue." Ramius tries to drive CYPB down to buy it for a bargain. CYPB is worth at least $8.
8/6/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

dukeduke
CYPB - I think it's reason to terminate deal with Forest Lab, for $2M is to allow it to be packaged to sell to highest bidder. No limitation
8/5/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Diversify
I now hold a position in CYPB in expectation that a higher offer than the Ramius hedge fund buy-out a $4 will be announced.
7/24/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES